BioSpace News Archive

Newron Pharmaceuticals S.p.A. announced that it will present three posters at the upcoming 36th European College of Neuropsychopharmacology (ECNP) Congress taking place October 7-10, 2023, at the Centre Convencions Internacional de Barcelona (CCIB) in Barcelona, Spain.

Vedanta Biosciences today announced that the first patient in the Phase 2 COLLECTiVE202 clinical study of VE202 was dosed.

Amwell ® to Participate in Key HLTH 2023 Engagements.

ROME Therapeutics today announced the appointment of biopharma executive leader and finance expert Kyle Kuvalanka as Chief Financial Officer and Chief Business Officer.

Bruker Corporation (Nasdaq: BRKR) today announced a majority investment in MIRO Analytical AG , an innovative provider of fast, compact Quantum Cascade Laser (QCL)-based multi-gas analyzers for simultaneous, highest-precision monitoring of up to 10 trace gases.

Moderna, Inc. (NASDAQ:MRNA) today announced positive interim results from the Phase 1/2 trial of mRNA-1083, an investigational combination vaccine against influenza and COVID-19.

SwanBio Therapeutics today announced it has begun the second dose-escalation cohort of its first interventional clinical study, PROPEL.

Beyond Cancer, Ltd., an affiliate of Beyond Air, Inc. (NASDAQ: XAIR) that is developing ultra-high concentration nitric oxide (UNO) as an immunotherapeutic for solid tumors, today announced that Beyond Cancer, Ltd. will present two proffered posters at the upcoming American Association for Cancer Research-National Cancer Institute-European Organisation for Research and Treatment of Cancer.

Kura Oncology, Inc. today announced that three abstracts have been accepted for poster presentation at the upcoming AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics in Boston on October 13, 2023.

Vivos Therapeutics, Inc. today announced two key strategic agreements that will expand Vivos’ current product line and are expected to create near term additional revenue opportunities.